Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127706841 | 12770684 | 1 | I | 20160914 | 20160922 | 20160922 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-076867 | BRISTOL MYERS SQUIBB | 75.00 | YR | F | Y | 0.00000 | 20160922 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127706841 | 12770684 | 1 | PS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | U | 125118 | 750 | MG | SOLUTION FOR INFUSION | ||||||
| 127706841 | 12770684 | 2 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127706841 | 12770684 | 3 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | U | 0 | ||||||||||
| 127706841 | 12770684 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | UNK, QWK | U | 0 | /wk | ||||||||
| 127706841 | 12770684 | 5 | SS | FENTANYL. | FENTANYL | 1 | Unknown | U | 0 | ||||||||||
| 127706841 | 12770684 | 6 | SS | CELEBREX | CELECOXIB | 1 | Oral | U | 0 | ||||||||||
| 127706841 | 12770684 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 2.5 MG, UNK | U | 0 | 2.5 | MG | |||||||
| 127706841 | 12770684 | 8 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
| 127706841 | 12770684 | 9 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | 50 MG, UNK | U | 0 | 50 | MG | /wk | ||||||
| 127706841 | 12770684 | 10 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, QH | U | 0 | 50 | MG | /hr | ||||||
| 127706841 | 12770684 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 1000 MG, QH | U | 0 | 1000 | MG | /hr | ||||||
| 127706841 | 12770684 | 12 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | UNK, QH | U | 0 | /hr | ||||||||
| 127706841 | 12770684 | 13 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, QH | U | 0 | 5 | MG | /hr | ||||||
| 127706841 | 12770684 | 14 | C | OMEGA-3 FATTY ACIDS | OMEGA-3 FATTY ACIDS | 1 | Unknown | 1200 MG, BID | U | 0 | 1200 | MG | BID | ||||||
| 127706841 | 12770684 | 15 | C | NORTRIPTYLINE HYDROCHLORIDE. | NORTRIPTYLINE HYDROCHLORIDE | 1 | Oral | 10 MG, QH | U | 0 | 10 | MG | /hr | ||||||
| 127706841 | 12770684 | 16 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 127706841 | 12770684 | 17 | C | NASONEX | MOMETASONE FUROATE | 1 | Unknown | UNK UNK, BID | U | 0 | BID | ||||||||
| 127706841 | 12770684 | 18 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | Unknown | 2.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 127706841 | 12770684 | 19 | C | GENTEAL /00445101/ | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | Unknown | U | 0 | ||||||||||
| 127706841 | 12770684 | 20 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 100 MG, BID | U | 0 | 100 | MG | BID | ||||||
| 127706841 | 12770684 | 21 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 127706841 | 12770684 | 22 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 127706841 | 12770684 | 23 | C | ACTONEL | RISEDRONATE SODIUM | 1 | Unknown | 36 MG, QWK | U | 0 | 36 | MG | /wk | ||||||
| 127706841 | 12770684 | 24 | C | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 750 MG, UNK | U | 0 | 750 | MG | |||||||
| 127706841 | 12770684 | 25 | C | ACETAMINOPHEN W/OXYCODONE HYDROCHLORIDE | 2 | Unknown | U | 0 | |||||||||||
| 127706841 | 12770684 | 26 | C | OXYCODONE TEREPHTHALATE | OXYCODONE TEREPHTHALATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127706841 | 12770684 | 1 | Product used for unknown indication |
| 127706841 | 12770684 | 2 | Product used for unknown indication |
| 127706841 | 12770684 | 3 | Product used for unknown indication |
| 127706841 | 12770684 | 4 | Rheumatoid arthritis |
| 127706841 | 12770684 | 5 | Product used for unknown indication |
| 127706841 | 12770684 | 6 | Product used for unknown indication |
| 127706841 | 12770684 | 7 | Product used for unknown indication |
| 127706841 | 12770684 | 8 | Rheumatoid arthritis |
| 127706841 | 12770684 | 9 | Rheumatoid arthritis |
| 127706841 | 12770684 | 10 | Product used for unknown indication |
| 127706841 | 12770684 | 11 | Product used for unknown indication |
| 127706841 | 12770684 | 12 | Product used for unknown indication |
| 127706841 | 12770684 | 13 | Product used for unknown indication |
| 127706841 | 12770684 | 14 | Product used for unknown indication |
| 127706841 | 12770684 | 15 | Product used for unknown indication |
| 127706841 | 12770684 | 16 | Product used for unknown indication |
| 127706841 | 12770684 | 17 | Product used for unknown indication |
| 127706841 | 12770684 | 18 | Product used for unknown indication |
| 127706841 | 12770684 | 19 | Dry eye |
| 127706841 | 12770684 | 20 | Product used for unknown indication |
| 127706841 | 12770684 | 21 | Product used for unknown indication |
| 127706841 | 12770684 | 22 | Product used for unknown indication |
| 127706841 | 12770684 | 23 | Product used for unknown indication |
| 127706841 | 12770684 | 24 | Product used for unknown indication |
| 127706841 | 12770684 | 25 | Pain |
| 127706841 | 12770684 | 26 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127706841 | 12770684 | OT |
| 127706841 | 12770684 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127706841 | 12770684 | Arthralgia | |
| 127706841 | 12770684 | Bone cyst | |
| 127706841 | 12770684 | Crohn's disease | |
| 127706841 | 12770684 | Deafness neurosensory | |
| 127706841 | 12770684 | Deformity | |
| 127706841 | 12770684 | Diarrhoea | |
| 127706841 | 12770684 | Drug ineffective | |
| 127706841 | 12770684 | Dry eye | |
| 127706841 | 12770684 | Exostosis | |
| 127706841 | 12770684 | Fatigue | |
| 127706841 | 12770684 | Hypersensitivity | |
| 127706841 | 12770684 | Joint swelling | |
| 127706841 | 12770684 | Mobility decreased | |
| 127706841 | 12770684 | Musculoskeletal stiffness | |
| 127706841 | 12770684 | Myocardial infarction | |
| 127706841 | 12770684 | Osteoarthritis | |
| 127706841 | 12770684 | Osteopenia | |
| 127706841 | 12770684 | Osteosclerosis | |
| 127706841 | 12770684 | Pain | |
| 127706841 | 12770684 | Pain in extremity | |
| 127706841 | 12770684 | Pleural fibrosis | |
| 127706841 | 12770684 | Renal impairment | |
| 127706841 | 12770684 | Skin lesion | |
| 127706841 | 12770684 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |